- Home
- NMFC vs NVCT Comparison
NMFC vs NVCT Comparison
Compare NMFC & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMFC | NVCT |
|---|---|---|
| Founded | 2010 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 745.2M | 721.2M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NMFC | NVCT |
|---|---|---|
| Price | $7.04 | $18.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $8.63 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 838.3K | 588.9K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | ★ 15.27% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.51 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.80 | $5.55 |
| 52 Week High | $10.90 | $29.28 |
Technical Indicators
Market Signals| Indicator | NMFC | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 39.48 | 53.61 |
| Support Level | $6.80 | $7.05 |
| Resistance Level | $7.31 | $29.28 |
| Average True Range (ATR) | 0.18 | 2.41 |
| MACD | 0.02 | -0.64 |
| Stochastic Oscillator | 47.06 | 6.40 |
Price Performance
Historical ComparisonAbout NMFC New Mountain Finance Corporation
New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.